Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Breast Cancer Clinical Trial

Official title: Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Status Completed

Clinical Trial Summary

The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.

Clinical Trial Description

• The screening breast MRI and mammography will be performed 6 months or longer after the last mammogram. For pre-menopausal women, the screening will be performed during the second week of the menstrual cycle to reduce cycle-related breast changes. As much as possible, the breast MRI and mammogram are to be performed on the same day.

• On the day of the breast imaging studies, the patient will also be asked to fill out a baseline breast health questionnaire, which includes questions on time since radiation therapy, prior screening history, history of prior benign breast biopsies, menopausal status, prior hormonal therapy use, etc.

• In patients with suspicious findings or findings highly suggestive of malignancy, the abnormal findings will be reviewed with the patient and recommendations will be made for a biopsy. ;

Related Conditions & MeSH terms

• Breast Cancer
• Hodgkin Disease
• Hodgkin's Disease

• NCT number: NCT00165412
• Study type: Observational
• Source: Dana-Farber Cancer Institute
• Status: Completed
• Start date: July 2005
• Completion date: May 2010